Rachel is the Director of the BARDA Alliance for Johnson & Johnson Innovation, based at JLABS Washington, DC. In this role, she manages the collaboration between JLABS and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, which is focused on emerging technologies and the advancement of medical countermeasures aimed at securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID).
Before joining JLABS, Rachel was the Chief of Staff for the National Evaluation System for health Technology Coordinating (NESTcc)—an initiative of the Medical Device Innovation Consortium (MDIC). Rachel helped lead the development of NESTcc and managed strategy and operations, including overseeing governance, communications, sustainability planning, and stakeholder engagement. Prior to her work at MDIC, Rachel was based at the Patient-Centered Outcomes Research Institute (PCORI), helping to launch the Patient-Centered Clinical Research Network (PCORnet), a national effort to engage patients and leverage electronic health data to improve the speed and efficiency of clinical research in the United States.
She received her MBA from Georgetown University and MPH in global health policy from The George Washington University.